Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children’s Oncology Group experience
Year: 2022
Type: article
Source: Bone Marrow Transplantation
Institutions: University of Rochester Medicine, Golisano Children's Hospital, University of Rochester, Children's Oncology Group, University of Southern California, Children's Hospital Los Angeles, Icahn School of Medicine at Mount Sinai, Children's Mercy Hospital, Children's Hospital of Philadelphia, The University of Texas MD Anderson Cancer Center, New York Medical College
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Blood and Marrow Transplant Clinical Trials Network, G3333293540, Re-Engineering the Clinical Research Enterprise, Children's Oncology Group Statistics and Data Center, COG NCTN Network Group Operations Center, Determinants of Relapse Risk After BMT for ALL, Children's Oncology Group Chair's Grant
OpenAlex ID: W4206218506
